May 19, 2006 11:05 ET Issues Update on (AMEX: TBV)

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.

LAKE HARMONY, PA -- (MARKET WIRE) -- May 19, 2006 -- issues a trader's update on Tiens Biotech Group (USA), Inc. (AMEX: TBV). TBV is up $.41 or 8% intraday after the company released news this morning regarding a first quarter revenue increase of 17% and a net income rise of 20.8%. The release states that as of March 31, 2006, Tiens USA had $75,848,769 of retained earnings and total shareholders' equity of $97,134,935. The company also discussed its loan to Tianshi Engineering, and its effort to qualify for a direct selling license in China.

Please visit for a TBV profile and to read the release in its entirety. is an online financial destination where money managers, analysts, and individual investors can converge to discover new and exciting investment news, opportunities, and ideas. is focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street.

Other active stocks are Tower Semiconductor Ltd. (NASDAQ: TSEM), Syntax-Brillian Corporation (NASDAQ: BRLC) and Champion Industries, Inc. (NASDAQ: CHMP).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $545.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information